Single-Domain Antibody Platforms Market Trends 2031
The Single-Domain Antibody Platforms Market is expected to register a CAGR of 9.3% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Single-Domain Antibody Platforms Market report covers analysis By Platform Type (Multi Specific Single Domain Antibody, Bispecific Single Domain Antibody, Multivalent Single Domain Antibody, Mono Specific Single Domain Antibody); Animal Source (Camelids, Shark); Application (Diagnostic Development, Therapeutic Development, Research and Developmental Activities); End User (Pharmaceutical land Biotechnology Companies, Academic and Research Institutes, Others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Single-Domain Antibody Platforms Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Single-Domain Antibody Platforms Market Segmentation
Platform Type- Multi Specific Single Domain Antibody
- Bispecific Single Domain Antibody
- Multivalent Single Domain Antibody
- Mono Specific Single Domain Antibody
- Camelids
- Shark
- Diagnostic Development
- Therapeutic Development
- Research and Developmental Activities
- Pharmaceutical land Biotechnology Companies
- Academic and Research Institutes
Strategic Insights
Single-Domain Antibody Platforms Market Growth Drivers- Demand for Targeted Therapies: The growing demand for targeted therapies, especially in the field of oncology and autoimmune diseases, is accelerating the growth of single-domain antibodies (sdAbs). Such antibodies have higher specificity and affinity for their target and are thus better suited for targeted therapies with minimal side effects compared to conventional monoclonal antibodies.
- Advantages in drug development: Single-domain antibodies are smaller, more stable, and easier to produce than conventional antibodies, so they are preferred in drug development. Their ability to bind to unique epitopes on antigens and penetrate tissues more effectively enhances their utility in therapeutic applications, which is driving market growth.
- Advances in Biotechnology and Immunotherapy: The adoption of single-domain antibodies has been significantly driven by advancements in biotechnology, specifically in immunotherapy. With unique properties, they find their applications in various types of immunotherapy approaches. In cancer immunotherapy, they can be used as immune checkpoint inhibitors or as targeted delivery systems.
- Increased Trends of Integration with Nanotechnology:
There is an increasing trend of integrating single-domain antibodies with nanotechnology. Conjugating nanoparticles, such as nanobodies, with sdAbs to achieve more efficient delivery of drugs or imaging agents to specific tissues or cells, is a possible aspect. This integration opens new applications in diagnostics and drug delivery systems.
- Expansion of Therapeutic Applications: These are increasingly being used for therapeutic purposes across a wide range of conditions, including infectious diseases, chronic conditions, and inflammatory diseases. The small size and the possibility of their easy manipulation into many forms of therapeutic targets expand the use of single-domain antibodies beyond oncology to wider therapeutic areas.
- Focus on Humanization and Reduction of Immunogenicity: The focus has been on the humanized single-domain antibodies with the reduction of immunogenicity and enhancement of biocompatibility. This will pave the way for bringing these sdAb therapies to clinical settings, especially chronic diseases and immunotherapies.
- Emerging Markets for Biopharmaceuticals: With biopharmaceuticals gaining prominence in the emerging markets of Asia-Pacific, Latin America, and the Middle East, significant opportunities exist for adopting single-domain antibodies. Investment is rising in these regions with respect to healthcare, research infrastructure, and biotechnology development, opening new doors to applications of sdAb.
- Collaboration and strategic partnerships: Collaboration among biotech firms, pharmaceutical firms, and academic institutes creates a way for the development and commercialization of the single-domain antibody platform. In these strategic partnerships, a partnership is being seen focusing on the combination of sdAbs with other technologies like CAR-T cell therapy or personalized medicine for innovative treatments.
- Growth in Companion Diagnostics and Personalized Medicine: Strong growth is predicted in areas of personalized medicine and companion diagnostics. Antibodies could be integrated with diagnostic capabilities to provide specific patient pools that may be benefited through particular therapies, especially for oncology, autoimmune diseases, and rare disorders.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Single-Domain Antibody Platforms Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Single-Domain Antibody Platforms Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Key companies of this market are: Creative BioLabs A, Synbio Technologies, ProSci Incorporated, BioCat GmbH, Antibody Design Labs, GenScript, Oak BioSciences, Inc., Rockland Immunochemicals, Inc, Hybrigenics Services.
Key future trends in this market are - Expansion in Oncology Therapeutics, Development of Multispecific Antibodies, Growing Interest in Non-Human Models
The Single-Domain Antibody Platforms Market is estimated to witness a CAGR of 9.3% from 2023 to 2031.
The major factors driving the market are: Focus on targeted therapies, Rising biopharma collaborations, Increased applications in diagnostics
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Single-Domain Antibody Platforms Market - By Platform Type
1.3.2 Single-Domain Antibody Platforms Market - By Animal Source
1.3.3 Single-Domain Antibody Platforms Market - By Application
1.3.4 Single-Domain Antibody Platforms Market - By End User
1.3.5 Single-Domain Antibody Platforms Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - GLOBAL MARKET ANALYSIS
6.1. SINGLE-DOMAIN ANTIBODY PLATFORMS - GLOBAL MARKET OVERVIEW
6.2. SINGLE-DOMAIN ANTIBODY PLATFORMS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - PLATFORM TYPE
7.1. OVERVIEW
7.2. PLATFORM TYPE MARKET FORECASTS AND ANALYSIS
7.3. MULTI SPECIFIC SINGLE DOMAIN ANTIBODY
7.3.1. Overview
7.3.2. Multi Specific Single Domain Antibody Market Forecast and Analysis
7.4. BISPECIFIC SINGLE DOMAIN ANTIBODY
7.4.1. Overview
7.4.2. Bispecific Single Domain Antibody Market Forecast and Analysis
7.5. MULTIVALENT SINGLE DOMAIN ANTIBODY
7.5.1. Overview
7.5.2. Multivalent Single Domain Antibody Market Forecast and Analysis
7.6. MONO SPECIFIC SINGLE DOMAIN ANTIBODY
7.6.1. Overview
7.6.2. Mono Specific Single Domain Antibody Market Forecast and Analysis
8. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - ANIMAL SOURCE
8.1. OVERVIEW
8.2. ANIMAL SOURCE MARKET FORECASTS AND ANALYSIS
8.3. CAMELIDS
8.3.1. Overview
8.3.2. Camelids Market Forecast and Analysis
8.4. SHARK
8.4.1. Overview
8.4.2. Shark Market Forecast and Analysis
9. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTIC DEVELOPMENT
9.3.1. Overview
9.3.2. Diagnostic Development Market Forecast and Analysis
9.4. THERAPEUTIC DEVELOPMENT
9.4.1. Overview
9.4.2. Therapeutic Development Market Forecast and Analysis
9.5. RESEARCH AND DEVELOPMENTAL ACTIVITIES
9.5.1. Overview
9.5.2. Research and Developmental Activities Market Forecast and Analysis
10. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICA LAND BIOTECHNOLOGY COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutica land Biotechnology Companies Market Forecast and Analysis
10.4. ACADEMIC AND RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Academic and Research Institutes Market Forecast and Analysis
10.5. OTHERS
10.5.1. Overview
10.5.2. Others Market Forecast and Analysis
11. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Single-Domain Antibody Platforms Market Overview
11.1.2 North America Single-Domain Antibody Platforms Market Forecasts and Analysis
11.1.3 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.1.4 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.1.5 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.1.6 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.1.7 North America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.1.7.1 United States Single-Domain Antibody Platforms Market
11.1.7.1.1 United States Single-Domain Antibody Platforms Market by Platform Type
11.1.7.1.2 United States Single-Domain Antibody Platforms Market by Animal Source
11.1.7.1.3 United States Single-Domain Antibody Platforms Market by Application
11.1.7.1.4 United States Single-Domain Antibody Platforms Market by End User
11.1.7.2 Canada Single-Domain Antibody Platforms Market
11.1.7.2.1 Canada Single-Domain Antibody Platforms Market by Platform Type
11.1.7.2.2 Canada Single-Domain Antibody Platforms Market by Animal Source
11.1.7.2.3 Canada Single-Domain Antibody Platforms Market by Application
11.1.7.2.4 Canada Single-Domain Antibody Platforms Market by End User
11.1.7.3 Mexico Single-Domain Antibody Platforms Market
11.1.7.3.1 Mexico Single-Domain Antibody Platforms Market by Platform Type
11.1.7.3.2 Mexico Single-Domain Antibody Platforms Market by Animal Source
11.1.7.3.3 Mexico Single-Domain Antibody Platforms Market by Application
11.1.7.3.4 Mexico Single-Domain Antibody Platforms Market by End User
11.2. EUROPE
11.2.1 Europe Single-Domain Antibody Platforms Market Overview
11.2.2 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis
11.2.3 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.2.4 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.2.5 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.2.6 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.2.7 Europe Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Single-Domain Antibody Platforms Market
11.2.7.1.1 Germany Single-Domain Antibody Platforms Market by Platform Type
11.2.7.1.2 Germany Single-Domain Antibody Platforms Market by Animal Source
11.2.7.1.3 Germany Single-Domain Antibody Platforms Market by Application
11.2.7.1.4 Germany Single-Domain Antibody Platforms Market by End User
11.2.7.2 France Single-Domain Antibody Platforms Market
11.2.7.2.1 France Single-Domain Antibody Platforms Market by Platform Type
11.2.7.2.2 France Single-Domain Antibody Platforms Market by Animal Source
11.2.7.2.3 France Single-Domain Antibody Platforms Market by Application
11.2.7.2.4 France Single-Domain Antibody Platforms Market by End User
11.2.7.3 Italy Single-Domain Antibody Platforms Market
11.2.7.3.1 Italy Single-Domain Antibody Platforms Market by Platform Type
11.2.7.3.2 Italy Single-Domain Antibody Platforms Market by Animal Source
11.2.7.3.3 Italy Single-Domain Antibody Platforms Market by Application
11.2.7.3.4 Italy Single-Domain Antibody Platforms Market by End User
11.2.7.4 Spain Single-Domain Antibody Platforms Market
11.2.7.4.1 Spain Single-Domain Antibody Platforms Market by Platform Type
11.2.7.4.2 Spain Single-Domain Antibody Platforms Market by Animal Source
11.2.7.4.3 Spain Single-Domain Antibody Platforms Market by Application
11.2.7.4.4 Spain Single-Domain Antibody Platforms Market by End User
11.2.7.5 United Kingdom Single-Domain Antibody Platforms Market
11.2.7.5.1 United Kingdom Single-Domain Antibody Platforms Market by Platform Type
11.2.7.5.2 United Kingdom Single-Domain Antibody Platforms Market by Animal Source
11.2.7.5.3 United Kingdom Single-Domain Antibody Platforms Market by Application
11.2.7.5.4 United Kingdom Single-Domain Antibody Platforms Market by End User
11.2.7.6 Rest of Europe Single-Domain Antibody Platforms Market
11.2.7.6.1 Rest of Europe Single-Domain Antibody Platforms Market by Platform Type
11.2.7.6.2 Rest of Europe Single-Domain Antibody Platforms Market by Animal Source
11.2.7.6.3 Rest of Europe Single-Domain Antibody Platforms Market by Application
11.2.7.6.4 Rest of Europe Single-Domain Antibody Platforms Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Single-Domain Antibody Platforms Market Overview
11.3.2 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis
11.3.3 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.3.4 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.3.5 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Single-Domain Antibody Platforms Market
11.3.7.1.1 Australia Single-Domain Antibody Platforms Market by Platform Type
11.3.7.1.2 Australia Single-Domain Antibody Platforms Market by Animal Source
11.3.7.1.3 Australia Single-Domain Antibody Platforms Market by Application
11.3.7.1.4 Australia Single-Domain Antibody Platforms Market by End User
11.3.7.2 China Single-Domain Antibody Platforms Market
11.3.7.2.1 China Single-Domain Antibody Platforms Market by Platform Type
11.3.7.2.2 China Single-Domain Antibody Platforms Market by Animal Source
11.3.7.2.3 China Single-Domain Antibody Platforms Market by Application
11.3.7.2.4 China Single-Domain Antibody Platforms Market by End User
11.3.7.3 India Single-Domain Antibody Platforms Market
11.3.7.3.1 India Single-Domain Antibody Platforms Market by Platform Type
11.3.7.3.2 India Single-Domain Antibody Platforms Market by Animal Source
11.3.7.3.3 India Single-Domain Antibody Platforms Market by Application
11.3.7.3.4 India Single-Domain Antibody Platforms Market by End User
11.3.7.4 Japan Single-Domain Antibody Platforms Market
11.3.7.4.1 Japan Single-Domain Antibody Platforms Market by Platform Type
11.3.7.4.2 Japan Single-Domain Antibody Platforms Market by Animal Source
11.3.7.4.3 Japan Single-Domain Antibody Platforms Market by Application
11.3.7.4.4 Japan Single-Domain Antibody Platforms Market by End User
11.3.7.5 South Korea Single-Domain Antibody Platforms Market
11.3.7.5.1 South Korea Single-Domain Antibody Platforms Market by Platform Type
11.3.7.5.2 South Korea Single-Domain Antibody Platforms Market by Animal Source
11.3.7.5.3 South Korea Single-Domain Antibody Platforms Market by Application
11.3.7.5.4 South Korea Single-Domain Antibody Platforms Market by End User
11.3.7.6 Rest of Asia-Pacific Single-Domain Antibody Platforms Market
11.3.7.6.1 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by Platform Type
11.3.7.6.2 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by Animal Source
11.3.7.6.3 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by Application
11.3.7.6.4 Rest of Asia-Pacific Single-Domain Antibody Platforms Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Single-Domain Antibody Platforms Market Overview
11.4.2 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis
11.4.3 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.4.4 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.4.5 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Single-Domain Antibody Platforms Market
11.4.7.1.1 South Africa Single-Domain Antibody Platforms Market by Platform Type
11.4.7.1.2 South Africa Single-Domain Antibody Platforms Market by Animal Source
11.4.7.1.3 South Africa Single-Domain Antibody Platforms Market by Application
11.4.7.1.4 South Africa Single-Domain Antibody Platforms Market by End User
11.4.7.2 Saudi Arabia Single-Domain Antibody Platforms Market
11.4.7.2.1 Saudi Arabia Single-Domain Antibody Platforms Market by Platform Type
11.4.7.2.2 Saudi Arabia Single-Domain Antibody Platforms Market by Animal Source
11.4.7.2.3 Saudi Arabia Single-Domain Antibody Platforms Market by Application
11.4.7.2.4 Saudi Arabia Single-Domain Antibody Platforms Market by End User
11.4.7.3 U.A.E Single-Domain Antibody Platforms Market
11.4.7.3.1 U.A.E Single-Domain Antibody Platforms Market by Platform Type
11.4.7.3.2 U.A.E Single-Domain Antibody Platforms Market by Animal Source
11.4.7.3.3 U.A.E Single-Domain Antibody Platforms Market by Application
11.4.7.3.4 U.A.E Single-Domain Antibody Platforms Market by End User
11.4.7.4 Rest of Middle East and Africa Single-Domain Antibody Platforms Market
11.4.7.4.1 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by Platform Type
11.4.7.4.2 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by Animal Source
11.4.7.4.3 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by Application
11.4.7.4.4 Rest of Middle East and Africa Single-Domain Antibody Platforms Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Single-Domain Antibody Platforms Market Overview
11.5.2 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis
11.5.3 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Platform Type
11.5.4 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Animal Source
11.5.5 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Application
11.5.6 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By End User
11.5.7 South and Central America Single-Domain Antibody Platforms Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Single-Domain Antibody Platforms Market
11.5.7.1.1 Brazil Single-Domain Antibody Platforms Market by Platform Type
11.5.7.1.2 Brazil Single-Domain Antibody Platforms Market by Animal Source
11.5.7.1.3 Brazil Single-Domain Antibody Platforms Market by Application
11.5.7.1.4 Brazil Single-Domain Antibody Platforms Market by End User
11.5.7.2 Argentina Single-Domain Antibody Platforms Market
11.5.7.2.1 Argentina Single-Domain Antibody Platforms Market by Platform Type
11.5.7.2.2 Argentina Single-Domain Antibody Platforms Market by Animal Source
11.5.7.2.3 Argentina Single-Domain Antibody Platforms Market by Application
11.5.7.2.4 Argentina Single-Domain Antibody Platforms Market by End User
11.5.7.3 Rest of South and Central America Single-Domain Antibody Platforms Market
11.5.7.3.1 Rest of South and Central America Single-Domain Antibody Platforms Market by Platform Type
11.5.7.3.2 Rest of South and Central America Single-Domain Antibody Platforms Market by Animal Source
11.5.7.3.3 Rest of South and Central America Single-Domain Antibody Platforms Market by Application
11.5.7.3.4 Rest of South and Central America Single-Domain Antibody Platforms Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. SINGLE-DOMAIN ANTIBODY PLATFORMS MARKET, KEY COMPANY PROFILES
14.1. CREATIVE BIOLABS A
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. SYNBIO TECHNOLOGIES
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. PROSCI INCORPORATED
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BIOCAT GMBH
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ANTIBODY DESIGN LABS
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GENSCRIPT
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. OAK BIOSCIENCES, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ROCKLAND IMMUNOCHEMICALS, INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. HYBRIGENICS SERVICES
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. NEOCLONE BIOTECHNOLOGY INTERNATIONAL LLC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Creative BioLabs A
2. Synbio Technologies
3. ProSci Incorporated
4. BioCat GmbH
5. Antibody Design Labs
6. GenScript
7. Oak BioSciences, Inc.
8. Rockland Immunochemicals, Inc
9. Hybrigenics Services
10. NeoClone Biotechnology International LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For